Sign in

CIK 0001889109

  • Large accelerated filer

BELITE BIO, INC

Sign in to watch
Ticker
BLTE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Other
Phone
+1 858-246-6240
Business address
12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
Former names
BELITE BIO, INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,300,711
in 4 filings, $32.3M under 10b5-1 plans

Net −$32,300,711. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −500 $162.04 $81K 14,000
2026-11-12 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −500 $164.68 $82K 13,500
2026-11-12 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −500 $166.82 $83K 13,000
2026-11-12 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −500 $170.41 $85K 12,500
2026-10-29 Chuang Hao-Yuan Chief Financial Officer Other acquisition +5,000 180,264
2026-10-29 Lin Yu-Hsin Chief Executive Officer Other acquisition +5,000 187,949
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −200 $163.63 $33K 14,800
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −24 $164.64 $4K 14,776
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −120 $165.49 $20K 14,656
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −50 $166.44 $8K 14,606
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −78 $167.59 $13K 14,528
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −12 $168.21 $2K 14,516
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −14 $169.36 $2K 14,502
2026-10-01 Scholl Hendrik Peter Chief Medical Officer Sale 10b5-1 −2 $170.02 $340 14,500
2026-09-24 Chen Wan-Shan Director Option exercise +13,796 $0.44 $6K 37,259
2026-09-24 Chen Wan-Shan Director Option exercise · Stock Option (right to buy) −13,796 0
2026-09-08 Lin Yu-Hsin Chief Executive Officer Sale 10b5-1 −2,400 $194.33 $466K 93,734
2026-09-08 Lin Yu-Hsin Chief Executive Officer Sale 10b5-1 −6,090 $195.62 $1.2M 87,644
2026-09-08 Lin Yu-Hsin Chief Executive Officer Sale 10b5-1 −6,058 $196.54 $1.2M 81,586
2026-09-08 Lin Yu-Hsin Chief Executive Officer Sale 10b5-1 −8,752 $197.36 $1.7M 72,834

Page 1 of 10 · 190 trades